2021 Form 10-K Financial Statement

#000143774922007411 Filed on March 28, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $247.7M $65.50M $244.2M
YoY Change 1.4% -16.77% -24.49%
Cost Of Revenue $198.8M $54.90M $186.0M
YoY Change 6.93% -9.26% -24.98%
Gross Profit $48.83M $10.70M $58.28M
YoY Change -16.23% -41.53% -22.9%
Gross Profit Margin 19.71% 16.34% 23.86%
Selling, General & Admin $14.83M $2.800M $11.59M
YoY Change 27.94% -20.0% -9.76%
% of Gross Profit 30.38% 26.17% 19.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $39.97M $9.480M $39.64M
YoY Change 0.83% -27.08% -18.38%
% of Gross Profit 81.87% 88.6% 68.02%
Operating Expenses $14.83M $13.20M $11.59M
YoY Change 27.94% -20.96% -9.76%
Operating Profit -$6.044M -$2.500M $3.098M
YoY Change -295.09% -256.25% -95.06%
Interest Expense $8.048M -$1.500M $13.03M
YoY Change -38.23% -40.0% -18.55%
% of Operating Profit 420.59%
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0%
Pretax Income -$3.728M -$4.100M -$8.878M
YoY Change -58.01% -94.8% -89.2%
Income Tax $26.00K $600.0K -$2.658M
% Of Pretax Income
Net Earnings -$3.754M -$4.700M -$6.220M
YoY Change -39.65% -92.14% -89.61%
Net Earnings / Revenue -1.52% -7.18% -2.55%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$122.6K -$154.1K -$203.9K
COMMON SHARES
Basic Shares Outstanding 30.61M 30.47M
Diluted Shares Outstanding 30.61M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.546M $8.000M $8.000M
YoY Change -68.18% -27.9% -11.11%
Cash & Equivalents $2.546M $8.041M $8.000M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $5.395M $7.300M $7.300M
YoY Change -26.1% -5.19% -5.19%
Inventory $17.71M $33.60M $33.60M
Prepaid Expenses $3.282M
Receivables $13.58M $14.41M $14.40M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $39.24M $63.33M $63.30M
YoY Change -38.01% -23.18% -23.18%
LONG-TERM ASSETS
Property, Plant & Equipment $302.8M $309.4M $309.4M
YoY Change -2.13% -6.17% -6.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.545M $3.181M $5.000M
YoY Change -29.1% 1.34% -7.41%
Other Assets $8.372M $8.258M $6.400M
YoY Change 30.81% -20.01% -20.0%
Total Long-Term Assets $314.7M $320.8M $320.8M
YoY Change -1.89% -6.52% -6.53%
TOTAL ASSETS
Total Short-Term Assets $39.24M $63.33M $63.30M
Total Long-Term Assets $314.7M $320.8M $320.8M
Total Assets $354.0M $384.1M $384.1M
YoY Change -7.84% -9.75% -9.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.84M $14.80M $14.80M
YoY Change 88.07% -8.07% -8.07%
Accrued Expenses $7.502M $7.200M $7.200M
YoY Change 4.19% 28.57% 28.57%
Deferred Revenue $300.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $23.10M $34.31M $39.80M
YoY Change -41.96% 3.83% 20.61%
Total Short-Term Liabilities $64.63M $71.21M $71.20M
YoY Change -9.23% 9.82% 9.88%
LONG-TERM LIABILITIES
Long-Term Debt $84.67M $97.31M $101.8M
YoY Change -16.83% -30.79% -27.6%
Other Long-Term Liabilities $15.60M $2.842M $19.00M
YoY Change -17.88% -30.36% -5.0%
Total Long-Term Liabilities $100.3M $123.7M $120.8M
YoY Change -17.0% -25.17% -24.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.63M $71.21M $71.20M
Total Long-Term Liabilities $100.3M $123.7M $120.8M
Total Liabilities $171.7M $194.9M $198.9M
YoY Change -13.65% -15.31% -15.04%
SHAREHOLDERS EQUITY
Retained Earnings $81.56M
YoY Change -8.38%
Common Stock $306.0K
YoY Change 0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $182.2M $185.3M $185.3M
YoY Change
Total Liabilities & Shareholders Equity $354.0M $384.1M $384.1M
YoY Change -7.84% -9.75% -9.75%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$3.754M -$4.700M -$6.220M
YoY Change -39.65% -92.14% -89.61%
Depreciation, Depletion And Amortization $39.97M $9.480M $39.64M
YoY Change 0.83% -27.08% -18.38%
Cash From Operating Activities $47.97M $18.47M $52.58M
YoY Change -8.75% 861.98% 37.48%
INVESTING ACTIVITIES
Capital Expenditures $28.05M -$6.700M $20.69M
YoY Change 35.59% -18.89% -41.78%
Acquisitions
YoY Change
Other Investing Activities $525.0K $0.00 $2.500M
YoY Change -79.0% -100.0% -53.18%
Cash From Investing Activities -$27.53M -$6.700M -$18.19M
YoY Change 51.32% 7.2% -39.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$26.69M -9.250M -$35.63M
YoY Change -25.08% -241.22% 140.26%
NET CHANGE
Cash From Operating Activities $47.97M 18.47M $52.58M
Cash From Investing Activities -$27.53M -6.700M -$18.19M
Cash From Financing Activities -$26.69M -9.250M -$35.63M
Net Change In Cash -$6.242M 2.520M -$1.240M
YoY Change 403.39% 13.51% -81.72%
FREE CASH FLOW
Cash From Operating Activities $47.97M $18.47M $52.58M
Capital Expenditures $28.05M -$6.700M $20.69M
Free Cash Flow $19.92M $25.17M $31.89M
YoY Change -37.52% 147.25% 1076.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30785000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30785000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30610000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30610000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2546000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8041000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3283000 USD
CY2021Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
23098000 USD
CY2020Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
34311000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4030000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13584000 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14414000 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5490000 USD
CY2021Q4 us-gaap Energy Related Inventory Coal
EnergyRelatedInventoryCoal
7699000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
41528000 USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
31409000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64626000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71210000 USD
CY2021Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
84667000 USD
CY2020Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
97307000 USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4510000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2850000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2824000 USD
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
14025000 USD
CY2020Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
16177000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8258000 USD
CY2021Q4 us-gaap Assets
Assets
353980000 USD
CY2020Q4 us-gaap Assets
Assets
384130000 USD
CY2021 dei Auditor Firm
AuditorFirmId
166
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Energy Related Inventory Coal
EnergyRelatedInventoryCoal
24663000 USD
CY2021Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
10015000 USD
CY2020Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
8903000 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2112000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3282000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
39239000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
63333000 USD
CY2021Q4 us-gaap Mineral Rights
MineralRights
115837000 USD
CY2020Q4 us-gaap Mineral Rights
MineralRights
115853000 USD
CY2021Q4 hnrg Buildings And Equipment Gross
BuildingsAndEquipmentGross
342782000 USD
CY2020Q4 hnrg Buildings And Equipment Gross
BuildingsAndEquipmentGross
352115000 USD
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
112575000 USD
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
93635000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
571194000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
561603000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
268370000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
252245000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
302824000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
309358000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3545000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3181000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8372000 USD
CY2020 us-gaap Revenues
Revenues
244241000 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
198840000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
185957000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39973000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1577000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2842000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
103119000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
123660000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
167745000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
194870000 USD
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
4000000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
4000000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
308000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
306000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104126000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103399000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
77801000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
81555000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
182235000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
185260000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
353980000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
384130000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243903000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
242084000 USD
CY2021 us-gaap Other Operating Income
OtherOperatingIncome
3763000 USD
CY2020 us-gaap Other Operating Income
OtherOperatingIncome
2157000 USD
CY2021 us-gaap Revenues
Revenues
247666000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39644000 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1588000 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1799000 USD
CY2021 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1504000 USD
CY2020 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1381000 USD
CY2021 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
3510000 USD
CY2020 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-0 USD
CY2021 us-gaap Exploration Expense
ExplorationExpense
482000 USD
CY2020 us-gaap Exploration Expense
ExplorationExpense
768000 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14833000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11594000 USD
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
253710000 USD
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
241143000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-6044000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
3098000 USD
CY2021 us-gaap Interest Expense
InterestExpense
8048000 USD
CY2020 us-gaap Interest Expense
InterestExpense
13030000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
10000000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
364000 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1054000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3728000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8878000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-598000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
26000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2060000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2658000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3754000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30614000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30446000
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
8510000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2060000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
364000 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1054000 USD
CY2021 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 USD
CY2020 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1125000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39973000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-6220000 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
10653000 USD
CY2021 hnrg Interest Expense Change In Estimated Fair Value Of Interest Rate Swaps
InterestExpenseChangeInEstimatedFairValueOfInterestRateSwaps
-3026000 USD
CY2020 hnrg Interest Expense Change In Estimated Fair Value Of Interest Rate Swaps
InterestExpenseChangeInEstimatedFairValueOfInterestRateSwaps
68000 USD
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2564000 USD
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2296000 USD
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
0 USD
CY2020 us-gaap Interest Expense Other
InterestExpenseOther
13000 USD
CY2021 hnrg Noncash Interest Expense Total
NoncashInterestExpenseTotal
-462000 USD
CY2020 hnrg Noncash Interest Expense Total
NoncashInterestExpenseTotal
2377000 USD
CY2021 us-gaap Interest Expense
InterestExpense
8048000 USD
CY2020 us-gaap Interest Expense
InterestExpense
13030000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3754000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-6220000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
26000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39644000 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1588000 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1799000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
10000000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
CY2021 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-317000 USD
CY2020 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-38000 USD
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-0 USD
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
14000 USD
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2564000 USD
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2296000 USD
CY2021 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1504000 USD
CY2020 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1381000 USD
CY2021 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
3510000 USD
CY2020 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-0 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1004000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1211000 USD
CY2021 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-830000 USD
CY2020 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-11166000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16964000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2893000 USD
CY2021 us-gaap Increase Decrease In Materials And Supplies
IncreaseDecreaseInMaterialsAndSupplies
1112000 USD
CY2020 us-gaap Increase Decrease In Materials And Supplies
IncreaseDecreaseInMaterialsAndSupplies
-2872000 USD
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1562000 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5215000 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10844000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1405000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
362000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3048000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47974000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52576000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28050000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20688000 USD
CY2021 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
525000 USD
CY2020 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
56000 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2310000 USD
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
0 USD
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
245000 USD
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
-0 USD
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
113000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27525000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18190000 USD
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
46249000 USD
CY2020 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
49662000 USD
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
20250000 USD
CY2020 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
7250000 USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000000 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
418000 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1903000 USD
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
274000 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
75000 USD
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
-0 USD
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1236000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26691000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35626000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6242000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1240000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12071000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13311000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5829000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12071000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2546000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8041000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3283000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4030000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5829000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12071000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
8720000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
10971000 USD
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8520000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1199000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
191530000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1211000 USD
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
75000 USD
CY2020 us-gaap Dividends
Dividends
1236000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-6220000 USD
CY2020 us-gaap Stockholders Equity Other
StockholdersEquityOther
50000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1004000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
185260000 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
275000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3754000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
182235000 USD
CY2021Q4 us-gaap Regulatory Assets
RegulatoryAssets
23500000 USD
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
16277000 USD
CY2019Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
15764000 USD
CY2021 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1504000 USD
CY2020 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1381000 USD
CY2021 hnrg Asset Retirement Obligation Change Of Estimate
AssetRetirementObligationChangeOfEstimate
3510000 USD
CY2020 hnrg Asset Retirement Obligation Change Of Estimate
AssetRetirementObligationChangeOfEstimate
-0 USD
CY2021 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
146000 USD
CY2020 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
868000 USD
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
14125000 USD
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
16277000 USD
CY2021Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
100000 USD
CY2020Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
100000 USD
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
14025000 USD
CY2020Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
16177000 USD
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1694000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1809000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8372000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8258000 USD
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
3800000 USD
CY2020Q4 us-gaap Inventory Adjustments
InventoryAdjustments
1600000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b><span style="text-decoration: underline; ">Use of Estimates in the Preparation of Financial Statements </span></b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual amounts could differ from those estimates. The most significant estimates included in the preparation of the financial statements relate to: (i) deferred income tax accounts, (ii) coal reserves, (iii) depreciation, depletion, and amortization, (iv) estimates relating to interest rate swaps, (v) estimates used in our impairment analysis and measurement of impairments, and (vi) estimates used in the calculation of our asset retirement obligations.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p>
CY2021Q4 hnrg Coal Supply Commitment
CoalSupplyCommitment
20.7
CY2021 hnrg Year Supply Commitments End
YearSupplyCommitmentsEnd
2027
CY2021Q4 hnrg Priced Coal Supply Commitment
PricedCoalSupplyCommitment
16.2
CY2021Q4 us-gaap Prepaid Mineral Royalties Noncurrent
PrepaidMineralRoyaltiesNoncurrent
6678000 USD
CY2020Q4 us-gaap Prepaid Mineral Royalties Noncurrent
PrepaidMineralRoyaltiesNoncurrent
6449000 USD
CY2021Q4 hnrg Longterm Debt Current Maturities Gross
LongtermDebtCurrentMaturitiesGross
25725000 USD
CY2020Q4 hnrg Longterm Debt Current Maturities Gross
LongtermDebtCurrentMaturitiesGross
36750000 USD
CY2021Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
2627000 USD
CY2020Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
2439000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
23098000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34311000 USD
CY2021Q4 hnrg Longterm Debt Excluding Current Maturities Gross
LongtermDebtExcludingCurrentMaturitiesGross
86013000 USD
CY2020Q4 hnrg Longterm Debt Excluding Current Maturities Gross
LongtermDebtExcludingCurrentMaturitiesGross
100988000 USD
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1346000 USD
CY2020Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3681000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
84667000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
97307000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
111738000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
137738000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3973000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6120000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
107765000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
131618000 USD
CY2021Q4 hnrg Leverage Ratio
LeverageRatio
2.34 pure
CY2021Q4 hnrg Debt Service Coverage Ratio
DebtServiceCoverageRatio
1.11 pure
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
25725000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
86013000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
111738000 USD
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
27835000 USD
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
14785000 USD
CY2021Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
2529000 USD
CY2020Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
2566000 USD
CY2021Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
2413000 USD
CY2020Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
1621000 USD
CY2021Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
2560000 USD
CY2020Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
2988000 USD
CY2021Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
1800000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
1800000 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
867000 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2793000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
3524000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
4856000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
41528000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
31409000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
484000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
397000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
6000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-0 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
30858000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
26568000 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-783000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1865000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-767000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-644000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Depletion
IncomeTaxReconciliationNondeductibleExpenseDepletion
-1725000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Depletion
IncomeTaxReconciliationNondeductibleExpenseDepletion
-2154000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3376000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1275000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
380000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
67000 USD
CY2021 hnrg Income Tax Rate Reconciliation Ppp Loan Forgiveness
IncomeTaxRateReconciliationPppLoanForgiveness
-2100000 USD
CY2020 hnrg Income Tax Rate Reconciliation Ppp Loan Forgiveness
IncomeTaxRateReconciliationPppLoanForgiveness
0 USD
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1610000 USD
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-60000 USD
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
35000 USD
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
723000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2658000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
32659000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24081000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4651000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1275000 USD
CY2021Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
525000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
179000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
234000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
28008000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
23744000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
30368000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
26171000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2850000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2824000 USD
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30 pure
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
125000000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
158000000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000000.0 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1200000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2009Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
250000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
86383
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
1 pure
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04 pure
CY2021Q4 hnrg Participants In Employee Health Plan
ParticipantsInEmployeeHealthPlan
2274 pure
CY2021 hnrg Health Care Cap Per Person
HealthCareCapPerPerson
200000 USD
CY2021 hnrg Insured Capped Maximum Exposure Health Care
InsuredCappedMaximumExposureHealthCare
16600000 USD
CY2021 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
13084000 USD
CY2020 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
13173000 USD
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1946000 USD
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1797000 USD
CY2021 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
698000 USD
CY2020 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
679000 USD
CY2021 hnrg Employee Benefit Costs
EmployeeBenefitCosts
15728000 USD
CY2020 hnrg Employee Benefit Costs
EmployeeBenefitCosts
15649000 USD
CY2021 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
2900000 USD
CY2020 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
1900000 USD
CY2021 hnrg Insured Maximum Exposure Per Employee
InsuredMaximumExposurePerEmployee
1000000 USD
CY2021Q4 hnrg Aggregate Insurance Deductible For Employees
AggregateInsuranceDeductibleForEmployees
4000000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
174000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
60000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
441000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17000 USD
CY2021 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
3323000 USD
CY2021Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
-867000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
199000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M15D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060 pure
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
207000 USD
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-3754000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-6220000 USD
CY2021 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
-35000 USD
CY2020 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
-94000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3719000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6126000 USD
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30614000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30446000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
867000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4190000 USD
CY2019Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
-3800000 USD
CY2020 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
-390000 USD
CY2020Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
-4190000 USD

Files In Submission

Name View Source Status
0001437749-22-007411-index-headers.html Edgar Link pending
0001437749-22-007411-index.html Edgar Link pending
0001437749-22-007411.txt Edgar Link pending
0001437749-22-007411-xbrl.zip Edgar Link pending
ex_319540.htm Edgar Link pending
ex_319541.htm Edgar Link pending
ex_319542.htm Edgar Link pending
ex_319543.htm Edgar Link pending
ex_319544.htm Edgar Link pending
ex_319545.htm Edgar Link pending
ex_319546.htm Edgar Link pending
ex_349318.htm Edgar Link pending
ex_349318img001.jpg Edgar Link pending
ex_349318img006.gif Edgar Link pending
ex_351171.htm Edgar Link pending
figure1-1.jpg Edgar Link pending
figure101.jpg Edgar Link pending
figure111.jpg Edgar Link pending
figure112.jpg Edgar Link pending
figure113.jpg Edgar Link pending
figure114.jpg Edgar Link pending
figure3-1.jpg Edgar Link pending
figure4-2.jpg Edgar Link pending
figure41stratigraphic.jpg Edgar Link pending
figure5-1.jpg Edgar Link pending
figure6-2.jpg Edgar Link pending
figure6-3.jpg Edgar Link pending
figure6-4.jpg Edgar Link pending
figure6-5.jpg Edgar Link pending
figure61.jpg Edgar Link pending
figure66.jpg Edgar Link pending
figure71.jpg Edgar Link pending
figure8-1.jpg Edgar Link pending
figure8-2.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hnrg-20211231.xsd Edgar Link pending
hnrg-20211231_cal.xml Edgar Link unprocessable
hnrg-20211231_def.xml Edgar Link unprocessable
hnrg-20211231_lab.xml Edgar Link unprocessable
hnrg-20211231_pre.xml Edgar Link unprocessable
hnrg20211231_10k.htm Edgar Link pending
hnrg20211231_10k_htm.xml Edgar Link completed
insetmap2-2022.jpg Edgar Link pending
logo.jpg Edgar Link pending
logo2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sig01.jpg Edgar Link pending
table125.jpg Edgar Link pending
table51ivs.jpg Edgar Link pending
table91.jpg Edgar Link pending